Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare epileptic encephalopathy of childhood characterized by seizures, an electroencephalographic (EEG) pattern of electrical status epilepticus in sleep (ESES) and neurocognitive regression in at least 2 domains of development. This syndrome encompasses the previous syndromes epileptic encephalopathy with continuous spike-wave in sleep and atypical childhood epilepsy with centrotemporal spikes (also previously known as pseudo-Lennox syndrome and atypical benign partial epilepsy).
Biomarker and diagnostic research for developmental and/or epileptic encephalopathy with spike-wave activation in sleep has been reported in the published literature.
No clinical trials have been registered for developmental and/or epileptic encephalopathy with spike-wave activation in sleep.
222 publications have been identified in PubMed for developmental and/or epileptic encephalopathy with spike-wave activation in sleep. Kisho has analyzed 160 by research type. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (19%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 59 |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:03 AM UTC
Research summaries | 31 | 19% |
Clinical study results | 21 | 13% |
Disease patterns and progression | 19 | 12% |
Patient case studies | 15 | 9% |
Testing and diagnosis research | 8 | 5% |
New treatment approaches | 4 | 3% |
Other research | 3 | 2% |
Singh S (2026). [PMID: 41270422](https://pubmed.ncbi.nlm.nih.gov/41270422/). *Seizure*. [Clinical Trial Publication]
Specchio N (2026). [PMID: 42047579](https://pubmed.ncbi.nlm.nih.gov/42047579/). *Epilepsia*. [Review / Meta-Analysis]
Amrutkar CV (2026). [PMID: 30422560](https://pubmed.ncbi.nlm.nih.gov/30422560/). *Unknown Journal*. [Review / Meta-Analysis]
Balaram N (2026). [PMID: 42247783](https://pubmed.ncbi.nlm.nih.gov/42247783/). *Epilepsy Behav*. [Epidemiology / Natural History]
van Arnhem MML (2026). [PMID: 41133317](https://pubmed.ncbi.nlm.nih.gov/41133317/). *Epilepsia*. [Clinical Trial Publication]
Ezz MA (2026). [PMID: 41928388](https://pubmed.ncbi.nlm.nih.gov/41928388/). *Syst Biol Reprod Med*. [Review / Meta-Analysis]
Balasundaram P (2026). [PMID: 34033328](https://pubmed.ncbi.nlm.nih.gov/34033328/). *Unknown Journal*. [Case Report / Case Series]
Warrner E (2026). [PMID: 41667710](https://pubmed.ncbi.nlm.nih.gov/41667710/). *Nature biotechnology*. [Clinical Trial Publication]
Samanta D (2026). [PMID: 31985960](https://pubmed.ncbi.nlm.nih.gov/31985960/). *Unknown Journal*. [Review / Meta-Analysis]
Jerng HH (2026). [PMID: 41554648](https://pubmed.ncbi.nlm.nih.gov/41554648/). *J Neurosci*. [Basic Science / Preclinical]